These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23731442)

  • 1. Increased glycemic variability at the onset and during progression of type 2 diabetes-commentary.
    Rodbard D
    Diabetes Technol Ther; 2013 Jun; 15(6):445-7. PubMed ID: 23731442
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
    Madhu SV; Muduli SK; Avasthi R
    Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new measure of blood glucose variability in diabetes.
    Kovatchev BP; Otto E; Cox D; Gonder-Frederick L; Clarke W
    Diabetes Care; 2006 Nov; 29(11):2433-8. PubMed ID: 17065680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and diagnosis of prediabetes: where are we headed?
    Alberti KG
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():12-6. PubMed ID: 17877542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose monitoring in the acutely ill patient with diabetes mellitus.
    Quinn L
    Crit Care Nurs Q; 1998 Nov; 21(3):85-96. PubMed ID: 10646424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of post-prandial blood glucose excursions in type 1 and type 2 diabetes mellitus.
    Slama G
    Int J Clin Pract Suppl; 2000 Sep; (112):9-12. PubMed ID: 11064945
    [No Abstract]   [Full Text] [Related]  

  • 8. Focusing on potential sources of glucose fluctuations in type 1 and type 2 diabetes: which kind of patient, what kind of glycemic variability and which confounding factors?
    Chilelli NC; Sartore G; Lapolla A
    Diabetes Res Clin Pract; 2014 Oct; 106(1):e1-2. PubMed ID: 25128267
    [No Abstract]   [Full Text] [Related]  

  • 9. New insights from continuous glucose monitoring into the route to diabetes.
    Colas A; Vigil L; Rodríguez de Castro C; Vargas B; Varela M
    Diabetes Metab Res Rev; 2018 Jul; 34(5):e3002. PubMed ID: 29516622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1).
    Phillips LS; Weintraub WS; Ziemer DC; Kolm P; Foster JK; Vaccarino V; Rhee MK; Budhwani RK; Caudle JM
    Diabetes Care; 2006 Jun; 29(6):1405-7. PubMed ID: 16732034
    [No Abstract]   [Full Text] [Related]  

  • 11. [Erythrocyte aggregation in subjects with alterations in glucose metabolism during the preclinical phase].
    Giansanti R; De Tommaso G; Boemi M; Brachetti Felcini A; Fumelli P; Testa I
    Ric Clin Lab; 1989; 19 Suppl 1():169-71. PubMed ID: 2629081
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating human epidermal growth factor receptor 2 (HER2) is associated with hyperglycaemia and insulin resistance.
    Memon AA; Bennet L; Zöller B; Wang X; Palmer K; Sundquist K; Sundquist J
    J Diabetes; 2015 May; 7(3):369-77. PubMed ID: 24981162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous glucose monitoring: physiologic and pathophysiologic significance.
    Ionescu-Tîrgovişte C; Guja C; Ioacără S; Dumitrescu D; Tomescu I
    Rom J Intern Med; 2004; 42(2):381-93. PubMed ID: 15529628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current therapeutic strategy in type 1 diabetes and its preclinical stages].
    Martin S; Kolb H; Lampeter EF
    Internist (Berl); 1996 Dec; 37(12):1289-304. PubMed ID: 9081933
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycemic patterns detected by CGMS in patients with diabetes mellitus in the United Arab Emirates.
    Lessan NG; Abdullah A; Hassan H; Nasir Q; Athamneh S
    Diabetes Technol Ther; 2006 Aug; 8(4):513-5. PubMed ID: 16939376
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 17. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of subcutaneous insulin management protocols and order sets in inpatient diabetes management.
    Houlden RL; Moore S; Cornish W; Tiwana K
    Can J Diabetes; 2014 Apr; 38(2):101-17. PubMed ID: 24690505
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions.
    Fiorentino TV; Sesti F; Andreozzi F; Pedace E; Succurro E; Sciacqua A; Perticone F; Sesti G
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):439-41. PubMed ID: 27039961
    [No Abstract]   [Full Text] [Related]  

  • 20. Postload hyperglycemia is associated with increased subclinical inflammation in patients with prediabetes.
    Colak A; Akinci B; Diniz G; Turkon H; Ergonen F; Yalcin H; Coker I
    Scand J Clin Lab Invest; 2013 Aug; 73(5):422-7. PubMed ID: 23767858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.